ContextVision’s CEO Fredrik Palm discuss innovation around AI-powered diagnostic imaging and digital pathology at Sweden Korea Business Summit

ContextVision has been chosen to participate in this year’s Sweden Korea Business Summit organized by Business Sweden on December 18. CEO, Fredrik Palm, will present in the healthcare track: “How AI transforms the Future Healthcare, Opportunities and Challenges” and discuss innovation around AI-powered diagnostic imaging and digital pathology.

“South Korea is a key market for us, and also in the forefront of technology development. We’re excited to present on what we know best, AI-powered diagnostic imaging and digital pathology” said Palm.

“ContextVision is a leader in this space and we’re thrilled to be a part of the conversation.”.

Learn more about the summit here: https://www.business-sweden.se/Om-oss/nyhetsrum/Pressmeddelanden/large-swedish-business-delegation-to-south-korea-december-17-19/

For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 

 

About ContextVision
ContextVision is a medical technology software company that specializes in image analysis and artificial intelligence. As the global market leader within image enhancement, ContextVision is a software partner to leading medical imaging manufacturers around the world. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment.

As an industry pioneer for more than 30 years, ContextVision has developed state-of-the-art capabilities in the latest artificial intelligence technologies. By combining these with its well-established GOP technology, the company is introducing a new generation of image enhancement products. ContextVision is also approaching the growing digital pathology market with new AI-based decision support tools for pathologists.

The company is based in Sweden, with local representation in the U.S., Russia, Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker COV.